Progression-free survival at 2 years is a reliable surrogate marker for the 5-year survival rate in patients with locally advanced non-small cell lung cancer treated with chemoradiotherapy | BMC Cancer | Full
PLOS ONE: KAT6A amplifications are associated with shorter progression-free survival and overall survival in patients with endometrial serous carcinoma
Are progression-free and disease-free survival the new gold standard for cancer trials? | Cancer World Archive
Progression free survival rate at 9 and 18 weeks predict overall survival in patients with malignant pleural mesothelioma: An individual patient pooled analysis of 10 European Organisation for Research and Treatment of
Clinical Trial Endpoints in Cancer Research: Four Terms You Should Know
Progression-free survival and overall survival curves for all patients... | Download Scientific Diagram
View Image
Significance of baseline neutrophil-to-lymphocyte ratio for progression-free survival of patients with HER2-positive breast cancer treated with trastuzumab emtansine | Scientific Reports
Progression free survival and overall survival in patients treated with... | Download Scientific Diagram
Progression-free survival (PFS) (A) and overall survival (OS) (B) based... | Download Scientific Diagram
Comparison of overall survival and progression-free survival in... | Download Scientific Diagram
Ribociclib Improves Progression-free Survival in Advanced Breast Cancer | ESMO
Are progression-free and disease-free survival the new gold standard for cancer trials? | Cancer World Archive
The value of progression-free survival to patients with advanced-stage cancer | Semantic Scholar
OVERALL AND PROGRESSION-FREE SURVIVAL IN PATIENTS TREATED WITH.... EHA Library. Harrison C. Jun 9 2021; 324611
Predicting Real-World Effectiveness of Cancer Therapies Using Overall Survival and Progression-Free Survival from Clinical Trials: Empirical Evidence for the ASCO Value Framework - Value in Health
Progression free survival rate at 9 and 18 weeks predict overall survival in patients with malignant pleural mesothelioma: An individual patient pooled analysis of 10 European Organisation for Research and Treatment of
Kd vs Vd Study Results & Efficacy | KYPROLIS® (carfilzomib)
Differences in Treatment Effect Size Between Overall Survival and Progression-Free Survival in Immunotherapy Trials: A Meta-Epidemiologic Study of Trials With Results Posted at ClinicalTrials.gov | Journal of Clinical Oncology
Progression-free survival and time to progression as primary end points in advanced breast cancer: often used, sometimes loosely defined - Annals of Oncology
Progression-free survival as a surrogate endpoint for overall survival | OTT
Real world risk of infusion reactions and effectiveness of front-line obinutuzumab plus chlorambucil compared with other frontline treatments for chronic lymphocytic leukemia | SpringerLink
Extrapolation from Progression Free Survival to Overall Survival in O…
Progression-free survival and overall survival. Progression-free... | Download Scientific Diagram
Thalidomide maintenance treatment increases progression-free but not overall survival in elderly patients with myeloma | Haematologica
